Microbial bioburden within the wound bed environment is a major factor in the wound healing process. Anasept is a revolutionary wound care product by effectively inhibiting the colonization of these pathogenic microorganisms without the toxicity of other commonly used products. This reduction in wound bioburden without damaging healthy cells and tissue in the process is a tremendous resource for clinicians and patients they serve with acute to chronic, at-risk wounds. Anasept products are available in 2 forms depending on wound type:
- Anasept Antimicrobial Skin & Wound Cleanser
- Anasept Antimicrobial Skin & Wound Gel
ANASEPT ANTIMICROBIAL SKIN & WOUND CLEANSER (Anasept Spray):
Anasept Spray is a clear, isotonic liquid that helps in the mechanical removal of debris and foreign materials from the application site, by the action of the fluid (Wound Cleanser) moving across the wound bed or application site. Anasept Antimicrobial Skin and Wound Cleanser contains a broad-spectrum antimicrobial agent (.057% modified sodium hypochlorite) which effectively inhibits the growth of gram-positive and gram-negative bacteria such as Acinetobacter baumannii, Clostridium difficile, Escherichia coli, Proteus mirabilis, Pseudomonas aeruginosa, Serratia marcescens, Staphylococcus aureus, including antibiotic resistant strains and multi-drug resistant organisms, such as Carbapenem Resistant E. Coli (CRE), Methicillin Resistant Staphylococcus aureus (MRSA) and Vancomycin resistant Enterococcus faecalis (VRE) that are commonly found in wound bed, as well as fungi, such as Aspergillus niger, Candida albicans, and Candida auris. There are no known microbial resistances to Anasept Spray.
Anasept is a very pure, completely colorless, isotonic, tissue compatible solution. Anasept is stable for 2 years from date of manufacture, when stored at normal room temperature up to 25°C (77°F) and is free of necrotizing chemicals such as sodium hydroxide. Anasept is stable up to 14 weeks after initial use.
INDICATIONS FOR USE
Anasept is intended for OTC use for mechanical cleansing and removal of dirt, debris and foreign material from skin abrasions, lacerations, minor irritations, cuts, exit sites and intact skin.
Anasept is intended for use under the supervision of a healthcare professional for cleansing of foreign materials, including microorganisms from wounds such as stage I-IV pressure injuries, partial & full thickness wounds, diabetic foot ulcers, postsurgical wounds, first and second degree burns, grafted and donor sites.
ANASEPT ANTIMICROBIAL SKIN & WOUND GEL (Anasept Gel):
Anasept Gel is a clear, amorphous, isotonic hydrogel that helps maintain a moist wound environment that is conducive to healing, by either absorbing wound exudate or donating moisture while delivering 0.057% broad-spectrum antimicrobial modified sodium hypochlorite. Anasept Gel inhibits the growth of bacteria such as Acinetobacter baumannii, Clostridium difficile, Escherichia coli, Proteus mirabilis, Pseudomonas aeruginosa, Serratia marcescens, Staphylococcus aureus, including antibiotic resistant Carbapenem Resistant E. Coli (CRE), Methicillin Resistant Staphylococcus aureus (MRSA) and Vancomycin resistant Enterococcus faecalis (VRE) that are commonly found in wound bed, as well as fungi, such as Candida albicans, Candida auris and Aspergillus niger. There are no known microbial resistances to Anasept Gel.
INDICATIONS FOR USE
Anasept Gel is intended for OTC use for management of skin abrasions, minor irritations, lacerations, cuts, exit sites and intact skin.
Anasept Gel is intended to be used under the supervision of a healthcare professional in the management of wounds such as stage I-IV pressure injuries, partial & full thickness wounds, diabetic foot & leg ulcers, post surgical wounds, first & second degree burns, grafted & donor sites.
Anasept Gel additional benefits:
- assists in promoting quick and effective autolytic debridement
- Unmatched control of wound odor
- Cost Effective
- Medicare Reimbursement HCPCS Code # A6248
Anasept has been subjected to rigorous safety testing at an independent laboratory and shown to meet the criteria for safe use:
• Modified Primary Skin Irritation (FHSA method - 7 day exposure with repeated insult to intact and abraded skin)
• Cytotoxicity (IS0 Agarose Overlay method)
• Systemic toxicity (ISO Acute Systemic Toxicity)
• ISO Sensitization Study
CLINICALLY TESTED: Anasept is clinically proven to reduce wound bioburden levels and improve the rate of healing.